Section 3 (d) of the Indian Patent Act

The section 3 (d) of the Indian Patent Act, which was introduced in 2005, states that, for a new form of an existing substance to be patentable, it should show an ‘enhanced efficacy’. This section prevents pharmaceutical companies from evergreening…

November 21, 2014

India has biggest battlefield for IPR

A US lawmaker recently accused India of undermining intellectual property rights (IPR) of US pharma companies and of “rampant piracy and counterfeiting” by generic companies. These remarks were made in front of US Chamber of Commerce which released a report…